Last 12 months
Inside the activity.
1 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2024 Filed Apr 2, 2024 16:49 UTC |
DALY RICHARD JDirector · Executive Chairman
|
Tax withholdingCommon Stock | 438 | $203.23 | $89,014.74 |
DisclosureSEC source: 0001225208-24-004803 · doc4.xml · nonDerivative · entry 1 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,282.9949 Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:50 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
Tax withholdingCommon Stock | 928 | $203.23 | $188,597.44 |
DisclosureSEC source: 0001225208-24-004806 · doc4.xml · nonDerivative · entry 1 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,069.799 Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:49 UTC |
KALENKA ROBERT FCorporate Vice President
|
Tax withholdingCommon Stock | 692 | $203.23 | $140,635.16 |
DisclosureSEC source: 0001225208-24-004804 · doc4.xml · nonDerivative · entry 1 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,867.4097 Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:49 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
Tax withholdingCommon Stock | 703 | $203.23 | $142,870.69 |
DisclosureSEC source: 0001225208-24-004802 · doc4.xml · nonDerivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,776.8948 Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:49 UTC |
Reese EdmundCorporate VP and CFO
|
Tax withholdingCommon Stock | 2,896 | $203.23 | $588,554.08 |
DisclosureSEC source: 0001225208-24-004801 · doc4.xml · nonDerivative · entry 1 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,491.46 Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:49 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Tax withholdingCommon Stock | 3,362 | $203.23 | $683,259.26 |
DisclosureSEC source: 0001225208-24-004800 · doc4.xml · nonDerivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,288.521 Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 21:01 UTC |
keller brettDirector
|
GrantCommon Stock | 142 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004571 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,059 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 21:02 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 142 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004573 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,024 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 21:02 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 130 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004575 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,455 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 21:02 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 142 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004574 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,489 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 21:01 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 161 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004572 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,670.102 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| March 07, 2024 Filed Mar 7, 2024 19:27 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
SaleCommon Stock | 12,200 | $204.71 | $2,497,474.20 |
DisclosureSEC source: 0001225208-24-003837 · doc4.xml · nonDerivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,479.8948 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.6106 - $204.9600, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 22:18 UTC |
Duelks Robert NDirector
|
SaleCommon Stock | 830 | $201.58 | $167,311.40 |
DisclosureSEC source: 0001225208-24-003483 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · BOMAR II LLC Disclosed balance after: 5,445 Read SEC document |
| February 28, 2024 Filed Feb 28, 2024 18:20 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,712 | $0.00 Strike: $98.31 | $0.00 |
DisclosureSEC source: 0001225208-24-003187 · doc4.xml · derivative · entry 3 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,712 shares Expires 2029-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2024 Filed Feb 28, 2024 18:20 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 12,731 | $201.02 | $2,559,130.88 |
DisclosureSEC source: 0001225208-24-003187 · doc4.xml · nonDerivative · entry 2 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,303 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.77 - $201.58, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| February 28, 2024 Filed Feb 28, 2024 18:20 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionCommon Stock | 14,712 | $98.31 | $1,446,336.72 |
DisclosureSEC source: 0001225208-24-003187 · doc4.xml · nonDerivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 15, 2024 18:36 UTC |
KALENKA ROBERT FCorporate Vice President
|
GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002108 · doc4.xml · nonDerivative · entry 1 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,559.4097 F1 · price: The reported disposition represents a bona fide charitable gift made by the reporting person. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 13:03 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
GrantStock Option (Right to Buy) · Derivative | 1,895 | $0.00 Strike: $198.30 | $0.00 |
DisclosureSEC source: 0001225208-24-002273 · doc4.xml · derivative · entry 1 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,895 Underlying: Common Stock · 1,895 shares Expires 2034-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 18:03 UTC | GrantStock Option (Right to Buy) · Derivative | 106,920 | $0.00 Strike: $198.30 | $0.00 |
DisclosureSEC source: 0001225208-24-002271 · doc4.xml · derivative · entry 1 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,920 Underlying: Common Stock · 106,920 shares Expires 2034-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025. Read SEC document |
|
| February 15, 2024 Filed Feb 16, 2024 13:03 UTC |
DALY RICHARD JDirector · Executive Chairman
|
GrantStock Option (Right to Buy) · Derivative | 5,086 | $0.00 Strike: $198.30 | $0.00 |
DisclosureSEC source: 0001225208-24-002269 · doc4.xml · derivative · entry 1 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,086 Underlying: Common Stock · 5,086 shares Expires 2034-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 18:04 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
GrantStock Option (Right to Buy) · Derivative | 6,981 | $0.00 Strike: $198.30 | $0.00 |
DisclosureSEC source: 0001225208-24-002276 · doc4.xml · derivative · entry 1 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,981 Underlying: Common Stock · 6,981 shares Expires 2034-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 18:03 UTC |
Reese EdmundCorporate VP and CFO
|
GrantStock Option (Right to Buy) · Derivative | 25,932 | $0.00 Strike: $198.30 | $0.00 |
DisclosureSEC source: 0001225208-24-002275 · doc4.xml · derivative · entry 1 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,932 Underlying: Common Stock · 25,932 shares Expires 2034-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 18:03 UTC |
PERRY CHRISTOPHER JOHNPresident
|
GrantStock Option (Right to Buy) · Derivative | 29,921 | $0.00 Strike: $198.30 | $0.00 |
DisclosureSEC source: 0001225208-24-002274 · doc4.xml · derivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,921 Underlying: Common Stock · 29,921 shares Expires 2034-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 18:03 UTC |
KALENKA ROBERT FCorporate Vice President
|
GrantStock Option (Right to Buy) · Derivative | 4,438 | $0.00 Strike: $198.30 | $0.00 |
DisclosureSEC source: 0001225208-24-002272 · doc4.xml · derivative · entry 1 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,438 Underlying: Common Stock · 4,438 shares Expires 2034-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 18:03 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
GrantStock Option (Right to Buy) · Derivative | 5,735 | $0.00 Strike: $198.30 | $0.00 |
DisclosureSEC source: 0001225208-24-002270 · doc4.xml · derivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,735 Underlying: Common Stock · 5,735 shares Expires 2034-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 18:03 UTC |
Carey Thomas PCorporate VP
|
GrantStock Option (Right to Buy) · Derivative | 16,955 | $0.00 Strike: $198.30 | $0.00 |
DisclosureSEC source: 0001225208-24-002268 · doc4.xml · derivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,955 Underlying: Common Stock · 16,955 shares Expires 2034-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2025. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 15:44 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 27,778 | $50.95 Strike: $50.95 | $1,415,289.10 |
DisclosureSEC source: 0001225208-24-001716 · doc4.xml · derivative · entry 3 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,778 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 15:44 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
SaleCommon Stock | 22,722 | $199.00 | $4,521,684.82 |
DisclosureSEC source: 0001225208-24-001716 · doc4.xml · nonDerivative · entry 2 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,679.8948 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.0000 - $199.0600, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 15:44 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
Exercise / conversionCommon Stock | 27,778 | $50.95 | $1,415,289.10 |
DisclosureSEC source: 0001225208-24-001716 · doc4.xml · nonDerivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,401.8948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 17:27 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 79 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000601 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,646 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 17:27 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000602 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,682 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 17:27 UTC |
keller brettDirector
|
GrantCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000603 · doc4.xml · nonDerivative · entry 2 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,917 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 17:27 UTC |
keller brettDirector
|
GrantCommon Stock | 31 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000603 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,905 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 12:27 UTC |
BRUN LESLIE ADirector
|
GrantCommon Stock | 113 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000599 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,392 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 17:27 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000605 · doc4.xml · nonDerivative · entry 2 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,882 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 17:27 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000605 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,880 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 17:27 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000607 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,325 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 17:27 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000607 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,313 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 17:27 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000606 · doc4.xml · nonDerivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,347 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 17:27 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000606 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,341 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 17:27 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000604 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,509.102 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 17:27 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 53 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000604 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,495.102 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 17:27 UTC |
Carter Pamela LDirector
|
GrantCommon Stock | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000600 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,613 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| December 28, 2023 Filed Dec 28, 2023 18:52 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,438 | $148.07 Strike: $148.07 | $805,204.66 |
DisclosureSEC source: 0001225208-23-011357 · doc4.xml · derivative · entry 3 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,438 Underlying: Common Stock · 5,438 shares Expires 2031-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. Read SEC document |
| December 28, 2023 Filed Dec 28, 2023 18:52 UTC |
PERRY CHRISTOPHER JOHNPresident
|
SaleCommon Stock | 5,069 | $205.32 | $1,040,752.38 |
DisclosureSEC source: 0001225208-23-011357 · doc4.xml · nonDerivative · entry 2 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,650.521 F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.0000 - $205.3171, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| December 28, 2023 Filed Dec 28, 2023 18:52 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionCommon Stock | 5,438 | $148.07 | $805,204.66 |
DisclosureSEC source: 0001225208-23-011357 · doc4.xml · nonDerivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,719.521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. Read SEC document |
| December 26, 2023 Filed Dec 26, 2023 17:35 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,094 | $148.07 Strike: $148.07 | $1,050,408.58 |
DisclosureSEC source: 0001225208-23-011328 · doc4.xml · derivative · entry 6 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,876 Underlying: Common Stock · 7,094 shares Expires 2031-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. Read SEC document |
| December 26, 2023 Filed Dec 26, 2023 17:35 UTC |
PERRY CHRISTOPHER JOHNPresident
|
SaleCommon Stock | 6,643 | $200.17 | $1,329,702.07 |
DisclosureSEC source: 0001225208-23-011328 · doc4.xml · nonDerivative · entry 4 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,281.521 F2 · kind: The reported transaction is an open market sale pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.0000 - $200.2900, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4. Read SEC document |
| December 26, 2023 Filed Dec 26, 2023 17:35 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionCommon Stock | 7,094 | $148.07 | $1,050,408.58 |
DisclosureSEC source: 0001225208-23-011328 · doc4.xml · nonDerivative · entry 3 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,924.521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. Read SEC document |
| December 22, 2023 Filed Dec 26, 2023 17:35 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,906 | $148.07 Strike: $148.07 | $430,291.42 |
DisclosureSEC source: 0001225208-23-011328 · doc4.xml · derivative · entry 5 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,970 Underlying: Common Stock · 2,906 shares Expires 2031-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction is a stock option exercise pursuant to a 10b5-1 plan adopted by the reporting person on September 1, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.